TABLET COATINGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global Tablet Coatings Market Size and Forecast – 2025 to 2032

The Global Tablet Coatings Market is estimated to be valued at USD 958.9 million in 2025 and is expected to reach USD 1,413.1 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.

Key Takeaways of the Global Tablet Coatings Market:

• By type, film-coated tablets are expected to hold the largest market share at 23.3% in 2025, driven by their effectiveness in enhancing patient compliance and supporting product differentiation.
• By polymer type, cellulosic polymers are projected to account for the highest share at 39.2% in 2025, owing to their broad functionality, versatility, and strong industry adoption.
• In terms of functionality, non-functional non-modifying coatings are anticipated to dominate the market with a 37.3% share in 2025.
• North America is expected to lead the market, holding a share of 41.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 32.2% in 2025.

Market Overview:

The tablet coatings market is experiencing a significant upward trend, driven by the increasing demand for pharmaceutical products with improved palatability, enhanced shelf life, and better patient compliance. Manufacturers are focusing on developing advanced coating technologies and materials to cater to the growing needs of the pharmaceutical industry. Additionally, the rising prevalence of chronic diseases and the expanding geriatric population are contributing to the market's growth, as these factors lead to a higher consumption of tablets and capsules.

Currents Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Analysis

To learn more about this report, Request sample copy

Tablet Coatings Market Insights, By Polymer Type - Cellulosic Polymers Dominate the Market Due to Their Versatility and Functionality

In terms of polymer type, the cellulosic polymers segment is expected to contribute the highest share of the market with 39.2% in 2025 owing to their versatility, functionality, and widespread acceptance in the pharmaceutical industry. Cellulosic polymers, such as hydroxypropyl methylcellulose (HPMC), ethylcellulose (EC), and cellulose acetate phthalate (CAP), have gained significant popularity due to their excellent film-forming properties, compatibility with various active ingredients, and ability to control drug release.

One of the key factors driving the growth of the cellulosic polymers is their ability to form clear, transparent, and smooth coatings on tablet surfaces. These coatings not only enhance the aesthetic appeal of the tablets but also provide protection against moisture, light, and other environmental factors that can affect the stability of the active ingredients. Additionally, cellulosic polymers are known for their good mechanical properties, ensuring that the coatings remain intact during handling and transportation.

Tablet Coatings Market Insights, By Type - Film-Coated Tablets Lead the Market with Enhanced Patient Compliance and Product Differentiation

In terms of type, the film-coated tablets segment is expected to contribute the highest share of the market with 23.3% in 2025, primarily due to their ability to improve patient compliance and enable product differentiation. Film coating is a widely adopted technique in the pharmaceutical industry, as it offers several advantages over other coating methods.

One of the key drivers of the growth of film-coated tablets is their ability to enhance patient compliance. Film coatings can mask unpleasant tastes and odors of the active ingredients, making the tablets more palatable and easier to swallow. This is particularly important for pediatric and geriatric populations, who may have difficulty swallowing larger tablets or capsules. The improved taste and ease of administration can lead to better patient adherence to the prescribed medication regimen, ultimately resulting in improved therapeutic outcomes.

Another significant factor contributing to the high market share of film-coated tablets is the opportunity for product differentiation. Film coatings allow manufacturers to create visually appealing tablets with unique colors, logos, or branding elements. This not only helps in brand recognition but also reduces the risk of medication errors by making it easier for patients and healthcare professionals to identify the correct product. Furthermore, film coatings can be used to incorporate functional ingredients, such as flavors, sweeteners, or coloring agents, which can further enhance the patient experience and differentiate the product from competitors.

Tablet Coatings Market Insights, By Functionality - Non-Functional Non-Modifying Coatings Witness High Demand for Improved Aesthetics and Branding

Non-functional non-modifying coatings segment is expected to contribute the highest share of the market with 37.3% in 2025. Non-functional non-modifying coatings, often referred to as cosmetic or aesthetic coatings, are gaining significant traction in the global tablet coatings market. These coatings serve primarily to enhance the visual appeal and marketability of pharmaceutical and nutraceutical tablets without affecting the drug's pharmacokinetics or release profile. Unlike functional coatings that control drug release (e.g., delayed-release or sustained-release coatings), non-functional non-modifying coatings are applied for reasons such as uniform colouration, surface smoothness, brand identity, and patient compliance. Their application not only improves the product's aesthetic value but also aids in product differentiation, making it easier for consumers and healthcare professionals to identify and distinguish between different medications.

Regional Insights:

To learn more about this report, Request sample copy

North America Tablet Coatings Market Analysis and Trends

In North America, the dominance in the global tablet coatings market with an estimated share of 41.3% in 2025 can be attributed to several factors. The region boasts a well-established pharmaceutical industry, with the presence of numerous leading pharmaceutical companies and a robust research and development infrastructure. North America is projected to experience significant growth in the tablet coatings market over the forecast period. Key drivers include high treatment awareness among the population, rising pharmaceutical spending, and an increase in product launches and drug approvals across the region. Additionally, the growing geriatric population, which is more susceptible to health conditions requiring medication, further supports market expansion. For example, in July 2022, according to updated data from the US Census Bureau in 2021, 16.63% of the U.S. population was aged over 65, 65.0% fell within the 15–64 age group, and 18.37% were aged 0–14. With a population of approximately 320 million and steady growth over the past decade, the U.S. continues to demonstrate improved living standards—further contributing to the region’s positive market outlook.

Asia Pacific Tablet Coatings Market Analysis and Trends

Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth in the global tablet coatings market with a share of 32.2% in 2025. The region's rapid economic development, coupled with increasing healthcare expenditure and improving healthcare infrastructure, has fueled the demand for pharmaceutical products, including coated tablets. Countries like China and India have emerged as major pharmaceutical manufacturing hubs, attracting global players to establish their production facilities in the region. The large patient population, rising disposable incomes, and growing awareness about the benefits of advanced novel drug delivery systems have further contributed to the market's growth in Asia Pacific. Additionally, government initiatives to promote the pharmaceutical industry and favorable regulatory environments have encouraged local companies to invest in research and development, driving innovation in tablet coatings technology.

Global Tablet Coatings Market Outlook for Key Countries

U.S. Tablet Coatings Market Trends

The U.S. market for tablet coatings is characterized by its advanced healthcare system, strong research, and development capabilities, and the presence of major pharmaceutical companies. The country's emphasis on patient-centric healthcare and the increasing prevalence of chronic diseases have driven the demand for innovative tablet coating solutions. Key players in the U.S. tablet coatings market focus on developing novel coating materials and technologies to improve drug stability, release profiles, and patient compliance.

For example, Evonik Corporation contributes with its widely used EUDRAGIT range of polymers, essential for enteric and controlled-release applications. BASF Pharma Solutions supports the market with its Kollicoat product line, known for providing effective moisture protection and taste masking. Additionally, Dow plays a key role through its METHOCEL and ETHOCEL polymers, which are integral to achieving specific drug release profiles in coated tablets.

China Tablet Coatings Market Trends

China's market for tablet coatings has experienced significant growth in recent years, driven by the country's large population, increasing healthcare expenditure, and government support for the pharmaceutical industry. The country has become a global manufacturing hub for pharmaceutical products, including coated tablets. For example, in China, Huadong Medicine Co., Ltd. is actively involved in producing film-coated tablets for chronic conditions like diabetes and cardiovascular disorders, leveraging water-based coating technologies.

Shandong Xinhua Pharmaceutical stands out for its extensive production of cost-effective film-coated analgesics and antibiotics that are also exported to international markets. Shanghai Pharmaceuticals is enhancing drug release performance through the development of innovative polymeric coatings. Companies such as Nanjing Hicin Pharmaceutical specialise in enteric and sustained-release coatings for export-grade pharmaceuticals, supporting China's role as a global manufacturing hub for coated drugs.

U.K. Tablet Coatings Market Trends

The U.K. tablet coatings market is witnessing dynamic growth driven by advancements in pharmaceutical formulation technologies and a strong emphasis on patient-centric healthcare. One of the prominent trends is the increasing demand for functional coatings, particularly enteric and sustained-release coatings, which enhance drug efficacy and improve patient compliance. This demand is supported by the growing prevalence of chronic conditions such as cardiovascular diseases and diabetes, requiring long-term and controlled-release medications. For instance, on June 20, 2024, Adalvo, a global pharmaceutical company known for its agile and partnership-driven approach, announced the launch of Rivaroxaban Film-Coated Tablets in the U.K., developed as a generic to Xarelto. Rivaroxaban is prescribed for preventing atherothrombotic events in adults with ACS, CAD, or PAD.

Japan Tablet Coatings Market Trends

Japan continues to be a leading player in the global tablet coatings market, with a strong focus on innovation and quality. The country's advanced technological capabilities and strict regulatory standards have positioned it as a key market for tablet coatings. Japan remains a pioneer in advanced tablet coating technologies, with Fuji Chemical Industry Co., Ltd. offering premium excipients like Neusilin and Fujicalin, which improve tablet compressibility and stability in coating processes.

Shionogi & Co., Ltd. is known for integrating precision film coating in its antiretroviral and pain management drugs to ensure targeted drug delivery. Daiichi Sankyo manufactures enteric-coated formulations for cardiovascular and anti-inflammatory drugs therapies, using high-end coating lines that adhere to strict Japanese quality standards. Meanwhile, Kowa Company Ltd. develops multi-layer film-coated tablets for metabolic disorders with controlled release profiles, enhancing therapeutic outcomes.

End User Feedback and Unmet Needs

• End users across the pharmaceutical and nutraceutical industries have expressed mixed experiences with tablet coating technologies, reflecting both appreciable advances and ongoing limitations. Positive feedback has often focused on the performance of high-quality film coatings that improve tablet swallowability, visual appeal, and moisture protection—critical for product stability and consumer compliance. For instance, a major Indian generics manufacturer noted increased patient adherence after adopting a high-gloss Opadry coating, citing smoother ingestion and brand differentiation as key benefits. Conversely, recurring concerns have emerged from smaller contract manufacturers and public sector procurement bodies, particularly in cost-sensitive markets. These users frequently report challenges in achieving consistent coating uniformity due to complex process parameters and limited formulation flexibility, especially with low-solubility APIs or high-potency compounds.
• Despite technological advancements, the tablet coatings market continues to face notable unmet needs. Many users demand greater customization in coating functionalities (e.g., targeted release profiles or allergen-free compositions) without escalating cost or processing complexity. Additionally, limited compatibility with emerging continuous manufacturing systems and inadequate technical support in developing regions pose operational bottlenecks. Addressing these gaps—through modular coating systems, scalable automation tools, and localized service infrastructure—could unlock significant market opportunities. Not only would it enhance manufacturer loyalty and downstream product quality, but it would also enable differentiation in increasingly competitive and regulatory-driven markets.

Market Players, Key Developments, and Competitive Intelligence:

To learn more about this report, Request sample copy

Key Developments:

• In April 2025, Ashland Inc., a global specialty materials company, completed a USD 10 million expansion of its pharmaceutical manufacturing facility in Cabreúva, Brazil, enhancing production capacity for its Aquarius tablet coatings. The company also commissioned advanced microbial protection capabilities at its São Paulo R&D center, strengthening its presence in Latin America.
• In February 2025, Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, unveiled a new high-performance coatings platform designed for the pharmaceutical, nutraceutical, and OTC sectors. The platform features Tabshield and ReadiLYCOAT ready-to-use coating systems, offering immediate and enteric release options, sugar-free coatings, and plant-based polymers.
• In January 2024, Colorcon Inc, a global leader in film coatings and pharmaceutical excipients, launched a new Opadry coating system—free from titanium dioxide (TiO₂) and based on polyvinyl alcohol (PVA). Designed to meet regulatory and consumer concerns, especially in the EU, this high-opacity coating delivers effective performance at standard weight gain. The launch reflects Colorcon’s ongoing innovation in TiO₂-free solutions developed over the past five years to support safer, compliant pharmaceutical formulations.

Top Strategies Followed by Global Tablet Coatings Market Players

• Established players in the global tablet coatings market prioritize extensive research and development to innovate high-performance products. These companies invest heavily in R&D to develop advanced coating technologies that enhance the functionality, stability, and appeal of tablets. By focusing on innovation, they aim to stay ahead of the competition and cater to the evolving needs of the pharmaceutical industry.
  • For instance, in August 2024, Sigachi Industries, a leading Indian manufacturer of pharmaceutical excipients, has launched two innovative product lines—PureCoat (film coatings) and UltraMod (polymer blends). These solutions aim to enhance drug stability, bioavailability, and patient compliance.

• Mid-level players in the tablet coatings market focus on delivering cost-effective solutions to target price-sensitive consumers. They prioritize offering quality products at competitive prices, making tablet coatings more accessible to a wider customer base. By optimizing their production processes and leveraging economies of scale, these players can provide budget-friendly options without compromising on performance.
  • For instance, Kerry Group plc provides SheffCoat, a range of ready-to-use, aqueous-based tablet film coating systems designed for pharmaceutical applications. These coatings support immediate-release and enteric needs, are customizable in colour and functionality, and include titanium dioxide-free options.

• Small-scale players in the tablet coatings market often focus on niche specialization to differentiate themselves. They target specific market segments with unique features or innovative products that cater to particular customer requirements. By concentrating on niche markets, these players can establish a strong foothold and build a loyal customer base.
  • For example, Aesica Pharmaceuticals (Newcastle): Specialized in tailored coating technologies for orphan drugs and customized solid dosage forms before being integrated into Consort Medical.

Market Report Scope

Tablet Coatings Market Dynamics

To learn more about this report, Request sample copy

Tablet Coatings Market Driver - Increasing demand for pharmaceutical formulations

The global tablet coatings market is experiencing significant growth due to the increasing demand for pharmaceutical formulations. As the prevalence of various diseases and health conditions continues to rise worldwide, the need for effective and efficient drug delivery systems has become more crucial than ever. Tablet coatings play a vital role in enhancing the performance of pharmaceutical products by improving their stability, bioavailability, and patient compliance. Coatings can also mask unpleasant tastes, odors, and colors, making medications more palatable for patients. Moreover, the growing emphasis on controlled and sustained-release formulations has further fueled the demand for advanced tablet coating technologies.

Pharmaceutical companies are actively investing in research and development to create innovative coating solutions that can optimize drug release profiles and improve patient outcomes. As a result, the increasing demand for pharmaceutical formulations is expected to remain a key driver for the global tablet coatings market in the coming years. For instance, in April 2023, Corden Pharma launched its Drug Product Innovation Center of Excellence in Germany, focusing on enhancing bioavailability for oral solid dosage (OSD) formulations. The facility is specifically aimed at improving the performance of low bioavailability active pharmaceutical ingredients (APIs) in drug product manufacturing.

Tablet Coatings Market Opportunity - Expansion in emerging markets

The expansion of the global tablet coatings market into emerging markets presents a significant opportunity for growth and increased revenue. Emerging economies, such as those in Asia Pacific, Latin America, and Africa, have witnessed rapid economic development, population growth, and improvements in healthcare infrastructure. These factors have led to a rising demand for pharmaceutical products, including coated tablets.

By tailoring their products to meet the specific needs and preferences of local populations, companies can gain a competitive edge and capture a larger market share. Furthermore, collaborations with local pharmaceutical companies and distributors can help manufacturers navigate regulatory landscapes and distribution channels more effectively.

In February 2023, WuXi AppTec, a global provider of R&D and manufacturing services, expanded its collaboration with Cidara Therapeutics, a biotechnology company to support the advancement of Cidara’s Oncology Drug-Fc Conjugate Program. Under the enhanced agreement, the two companies will extend their ongoing partnership in Chemistry, Manufacturing, and Controls, CMC development and Good Manufacturing Practice GMC manufacturing, now incorporating additional applications for Cidara’s CD388 drug-Fc conjugate (DFC) targeting both influenza and oncology indications.

Analyst Opinion (Expert Opinion)

• The global tablet coatings market is witnessing robust growth, driven by rising demand for patient-friendly oral dosage forms, continuous pharmaceutical R&D, and stringent regulatory guidelines promoting quality and stability. Technological advancements such as titanium dioxide-free coatings and multifunctional polymers are enabling improved aesthetic appeal, controlled drug release, and brand differentiation. Moreover, growing investments in novel drug delivery systems and expanding geriatric and pediatric populations present significant opportunities for coating manufacturers. However, challenges such as high raw material costs, regulatory complexities, and limitations in coating uniformity continue to affect scalability and innovation across emerging markets.
• Conferences such as CPhI Worldwide, AAPS PharmSci 360 (U.S.), and Interphex Japan have played key roles in showcasing new excipient technologies and fostering global collaboration among formulators and regulatory bodies. Real-world initiatives, like Colorcon’s launch of titanium dioxide-free Opadry systems and Adalvo’s introduction of film-coated Rivaroxaban tablets in the U.K., reflect the industry's shift toward safe, compliant, and patient-centric products. Regulatory trends promoting transparency and green chemistry in pharmaceutical manufacturing are expected to further shape product development strategies and market competitiveness.

Market Segmentation

•  Polymer Type Insights (Revenue, USD Mn, 2020 - 2032)
• • Cellulosic Polymers
  • Vinyl Derivatives
  • Acrylic Polymers
  • Other Polymers
•  Type Insights (Revenue, USD Mn, 2020 - 2032)
• • Film-coated tablets
  • Sugar-coated tablets
  • Enteric-coated tablets
  • Gelatin-coated tablets
  • Compression coating
  • Electrostatic Coating
  • Aqueous Film Coating
  • Organic Coating
  • Dip Coating
  • Vacuum Film Coating
  • Other tablet coatings
•  Functionality Insights (Revenue, USD Mn, 2020 - 2032)
• • Non-functional non-modifying coatings
  • Functional modifying coatings
  • Functional non-modifying coatings
•  Release Profile Insights (Revenue, USD Mn, 2020 - 2032)
• • Immediate Release
  • Sustained Release
  • Delayed Release
•  Application Insights (Revenue, USD Mn, 2020 - 2032)
• • Pharmaceutical
  • Nutraceutical
  • Food Industry
  • Other Applications
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • BASF SE
  • Evonik Industries AG
  • Colorcon, Inc.
  • Dow Chemical Company
  • Ashland Global Holdings Inc.
  • Kuraray Co., Ltd.
  • Shin-Etsu Chemical Co., Ltd.
  • ROCHEM International
  • Lonza Group AG
  • Coating Place, Inc.
  • Associated British Foods plc
  • PPG Industries, Inc.
  • Pfizer Inc.
  • Grüne Erde GmbH
  • HPM Global

Sources

Primary Research Interviews:

• Pharmaceutical Manufacturing Engineers (formulation specialists)
• Procurement Managers at Contract Manufacturing Organizations (CMOs)
• Regulatory Affairs Officers at pharmaceutical companies
• Quality Control/Assurance Heads at tablet manufacturing facilities

Databases:

• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• Pharmaceuticals Export Promotion Council of India (Pharmexcil)
• World Health Organization (WHO)
• United Nations Comtrade Database
• India Ministry of Chemicals and Fertilizers
• Japan Pharmaceutical Manufacturers Association (JPMA)

Magazines:

• In-PharmaTechnologist
• Pharmaceutical Technology
• Tablets & Capsules (T&C)
• Contract Pharma
• The Medicine Maker
• Manufacturing Chemist
• European Pharmaceutical Review
• Pharma Manufacturing

Journals:

• Journal of Pharmaceutical Sciences
• European Journal of Pharmaceutical Sciences
• Drug Development and Industrial Pharmacy
• Journal of Controlled Release
• Journal of Drug Delivery Science and Technology
• Pharmaceutical Development and Technology

Newspapers:

• The Wall Street Journal – Health
• Financial Times – Pharma
• The Economic Times – Pharma
• Business Standard – Life Sciences
• Reuters Health

Associations:

• International Pharmaceutical Excipients Council (IPEC)
• American Association of Pharmaceutical Scientists (AAPS)
• European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Indian Drug Manufacturers’ Association (IDMA)
• Society of Cosmetic Chemists

Public Domain Sources:

• U.S. Patent and Trademark Office (USPTO)
• European Patent Office (EPO)
• Google Scholar
• gov
• Directory of Open Access Journals (DOAJ)

Proprietary Elements:

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years